400 Participants Needed

CHW Initiatives for Type 2 Diabetes

EV
VL
Overseen ByValeria Lescano
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Medical Branch, Galveston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial trains church members as Community Health Workers (CHWs) to improve diabetes care for Spanish-speaking Latino(a) adults. It focuses on enhancing healthcare access and quality through an online platform that addresses barriers faced by this community. Participants receive diabetes education and support through the Diabetes Program to better manage their condition. Suitable candidates are Spanish-speaking Latino(a) adults without Type 1 diabetes or certain severe mental health conditions. As an unphased trial, this study allows participants to contribute to innovative community health solutions while receiving valuable diabetes management support.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this diabetes program is safe?

Research shows that diabetes education programs are generally safe and well-tolerated by participants. Studies have demonstrated that people who join these programs often experience benefits such as better blood sugar control and healthier lifestyle choices. For example, participants in one program improved their blood sugar levels after attending the sessions. Another study found that the lifestyle changes taught in the program significantly reduced the risk of developing type 2 diabetes over time.

Major negative effects from diabetes education programs have not been reported, as these programs focus on teaching and support rather than medication or invasive treatments. This makes them low-risk and safe for most people.12345

Why are researchers excited about this trial?

Researchers are excited about the Diabetes Program because it offers a comprehensive approach beyond the standard medication and diet changes commonly used for Type 2 Diabetes. Unlike traditional treatments that focus primarily on managing blood sugar levels, this program emphasizes education and lifestyle changes, empowering individuals with knowledge and tools to manage their condition effectively. By integrating personalized education, the program aims to improve long-term health outcomes and potentially reduce dependency on medication.

What evidence suggests that this diabetes program is effective for improving healthcare access and quality for Latino(a)s?

Research has shown that diabetes education programs can greatly help people manage Type 2 diabetes. One study found that learning to manage diabetes independently helps individuals control their blood sugar levels better and feel more confident about handling their condition. Another study found that personalized diabetes education is more effective than group sessions for controlling diabetes. Additionally, these education programs are linked to better care, with many participants adopting important self-care habits. Specifically, diabetes education programs have led to significant improvements in A1c levels, a key measure of blood sugar control, over time. These findings suggest that diabetes education, such as the program being tested in this trial, can effectively help manage Type 2 diabetes.34678

Who Is on the Research Team?

EV

Elizabeth Vaughan, DO

Principal Investigator

University of Texas Medical Branch, Galveston

Are You a Good Fit for This Trial?

This trial is for Spanish-speaking Latino adults with Type 2 Diabetes. It's not suitable for those who are pregnant, planning to be pregnant soon, have Type 1 diabetes, or have certain mental health conditions like schizophrenia or severe Alzheimer's disease.

Inclusion Criteria

Spanish-speaking Latino(a)s adults

Exclusion Criteria

I do not speak Spanish.
I have been diagnosed with Type 1 diabetes.
Pregnant state or anticipated state in the next 6 months
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training

Church members are trained to become Community Health Workers (CHWs) and educated on diabetes management

4 weeks
Weekly training sessions

Intervention

Implementation of a 6-month church-based intervention for Latino(a)s with and at risk for diabetes, including the use of an online platform to track healthcare access and quality barriers

6 months
Monthly telementoring sessions

Follow-up

Participants are monitored for the effectiveness of the intervention, including CHW ability to use software and participant knowledge

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Diabetes Program
Trial Overview The study aims to train church members as Community Health Workers (CHWs) and use an online platform to improve healthcare access and quality for Latinos with diabetes. The effectiveness of this community-based diabetes program will be evaluated.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Diabetes program and educationExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Medical Branch, Galveston

Lead Sponsor

Trials
263
Recruited
55,400+

University of Houston

Collaborator

Trials
155
Recruited
48,600+

Baylor College of Medicine

Collaborator

Trials
1,044
Recruited
6,031,000+

Published Research Related to This Trial

In a study involving 116 participants, primarily Native Hawaiian and Samoan, community health workers (CHWs) significantly improved diabetes management, leading to a mean reduction in HbA1c of 2.2% for those receiving CHW support.
In contrast, participants without CHW intervention only experienced a minimal reduction of 0.2% in HbA1c, highlighting the effectiveness of CHWs in enhancing diabetes education and management in ethnic minority populations.
Diabetes management: utilizing community health workers in a Hawaiian/Samoan population.Beckham, S., Bradley, S., Washburn, A., et al.[2022]
Incretin-based therapies, such as DPP-4 inhibitors and GLP-1 agonists, provide effective glycemic control for type 2 diabetes patients without the weight gain often seen with traditional treatments, making them a favorable option for many.
Clinical trial data suggest that these therapies are safe, showing no negative effects on cardiovascular health, and their integration into treatment plans can enhance options for managing type 2 diabetes.
New therapeutic options: management strategies to optimize glycemic control.Freeman, JS.[2022]
The community health worker (CHW) program significantly improved patient satisfaction with accessing health services and community resources among 13 patients with type 2 diabetes.
Patients viewed the CHW program positively, indicating it could effectively address their health and social needs in safety net healthcare settings.
Patients' Perspectives on the Feasibility, Acceptability, and Impact of a Community Health Worker Program: A Qualitative Study.Chang, W., Oo, M., Rojas, A., et al.[2021]

Citations

Effectiveness of diabetes self-management education (DSME ...DSME has a positive effect on T2DM patients to improve their knowledge, behavior, self-efficacy, and clinical conditions of patients such as blood glucose ...
Effect of individualized diabetes education for type 2 ...Conclusion. Individualized diabetes education is more effective than group education in facilitating the control of type 2 diabetes.
Diabetes Education Linked to Better CareAmong people who received diabetes education, nearly 25% followed at least 9 of the 10 self-care and clinical care practices, compared to 10% ...
Comparative effectiveness of diabetes self-management ...A DSMES program in Texas reported statistically significant reductions in A1c levels at 3 months that were sustained at 6-, 9- and 12-month follow-up ...
NIDDK's Journey Into the Prevention of Type 2 Diabetes and ...After mean 2.8 years, ILS reduced diabetes risk by 58% and metformin by 31%, leading to study termination ahead of schedule due to demonstrated ...
Clinical outcomes of a diabetes education program for ...Based on our findings, the Micronesian patients with type 2 diabetes who attended the “Ohana” diabetes education program demonstrated improved HbA1c, FBG, and ...
New Data from Diabetes Prevention Program Outcomes ...The DPP demonstrated lifestyle intervention, aimed at achieving weight loss, and metformin treatment reduced the risk of T2D development by 58% and 31%, ...
Diabetes Care and Education: A Look Backward ...Studies on the effectiveness of diabetes education were also encouraging and gaining momentum, especially those focused on Diabetes Self- ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security